Alpha Fail: Ustekinumab to the Rescue After TNFα Failure in Patients with Moderate to Severe Crohn's Disease

G X H Liu; A S Day

doi:10.1007/s10620-025-09090-z

Back

Alpha Fail: Ustekinumab to the Rescue After TNFα Failure in Patients with Moderate to Severe Crohn's Disease

Editorial

Open access

Peer reviewed

Alpha Fail: Ustekinumab to the Rescue After TNFα Failure in Patients with Moderate to Severe Crohn's Disease

G X H Liu and A S Day

Digestive diseases and sciences

10/05/2025

DOI: https://doi.org/10.1007/s10620-025-09090-z

Handle:

https://hdl.handle.net/10523/46136

Abstract

commentary

Crohn’s Disease

Ustekinumab

Anti-TNF

Invited commentary on Latras-Cortés, I., Sáez Hortelano, J.C., Suárez-Álvarez, P. et al. 2025. Persistence and Efficacy of Ustekinumab in Crohn’s Disease After Anti-TNF Failure: An Observational Study. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-025-08978-0.

Files and links (1)

url

https://rdcu.be/emzNjView

Metrics

14 Record Views

Details

Record Identifier: 9926742463101891
Title: Alpha Fail: Ustekinumab to the Rescue After TNFα Failure in Patients with Moderate to Severe Crohn's Disease
Creators: G X H Liu
A S Day
Publication Details: Digestive diseases and sciences
Academic Unit: Paediatrics and Child Health (UOC)
Publisher: Springer Nature
Date published ; e-published: 10/05/2025
Copyright: Copyright © Springer Nature 2025. All rights reserved. This work was first published in Digestive Diseases and Sciences (Springer Nature). The open access link to the subscription article is provided under the Springer Nature SharedIt Content-Sharing Initiative (https://www.springernature.com/gp/researchers/sharedit) making the view-only full-text article freely and legally accessible to anyone for research purposes and private study via the link: https://rdcu.be/emzNj.
Language: English
Resource Type ; Subtype: Editorial